BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
Part of paid clinical trials in Chula Vista, California.
- Sponsor
- AstraZeneca
- Study ID
- NCT01498185
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Dapagliflozin — DRUGTablets, Oral, 1 mg, Once daily, 14 days
- Placebo matching Dapagliflozin — DRUGTablets, Oral, 0 mg, Once daily, 14 days
Study Details
To obtain safety and tolerability information in patients with type 1 diabetes where Dapagliflozin is added on to Insulin (for 14 days)
Key Dates
- Start date
- Feb 29, 2012
- Status verified
- Dec 2016
- Primary completion
- Oct 31, 2012
- Completion
- Oct 31, 2012
Study Design
- Enrollment
- 171 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Arm 1: Dapagliflozin (1 mg)
- Experimental: Arm 2: Dapagliflozin (2.5 mg)
- Experimental: Arm 3: Dapagliflozin (5 mg)
- Experimental: Arm 4: Dapagliflozin (10 mg)
- Experimental: Arm 5: Placebo matching Dapagliflozin
Primary Outcome Measure
Mean Change From Baseline in 7-Point Glucose Monitoring (7-PGM) at Day 7 [ Time Frame: From Baseline to Day 7 ]
Locations (12)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Profil Institute For Clinical Research, Inc. | Chula Vista | California | 91911 | - |
| Va San Diego Healthcare System | San Diego | California | 92161 | - |
| La Biomed Research Inst. At Harbor Ucla Med Ctr. | Torrance | California | 90502 | - |
| Compass Research Phase 1, Llc | Orlando | Florida | 32806 | - |
| Progressive Medical Research | Port Orange | Florida | 32127 | - |
| Vince And Associates Clinical Research | Overland Park | Kansas | 66212 | - |
| Central Kentucky Research Associates, Inc. | Lexington | Kentucky | 40509 | - |
| Louisiana Research Associates, Inc. | New Orleans | Louisiana | 70114 | - |
| Jasper Clinic, Inc. | Kalamazoo | Michigan | 49007 | - |
| Kansas City University Of Medicine And Biosciences | Kansas City | Missouri | 64106 | - |
| Regional Medical Clinic-Endocrinology | Rapid City | South Dakota | 57701 | - |
| Dallas Diabetes & Endocrine Center | Dallas | Texas | 75230 | - |
Find similar trials in Chula Vista, CA
By condition
By specialty
By research site
Profil Institute For Clinical Research, Inc.· Chula Vista, CAVa San Diego Healthcare System· San Diego, CALa Biomed Research Inst. At Harbor Ucla Med Ctr.· Torrance, CACompass Research Phase 1, Llc· Orlando, FLProgressive Medical Research· Port Orange, FLVince And Associates Clinical Research· Overland Park, KS
Related Studies
- Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft LossRecruiting · Rodolfo Alejandro · Miami, Florida
- Long Term Follow up of Recipients of Functional Islet AllograftsRecruiting · Rodolfo Alejandro · Miami, Florida
- Long Term Surveillance of Islet Transplant Recipients Following Complete Graft LossRecruiting · Rodolfo Alejandro · Miami, Florida
- Type 1 Diabetes Extension StudyRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California